Pfizer gets FDA priority review for Hympavzi to treat children 6-11 with hemophilia A or B, expanding current U.S. approvals.

Pharma giant Pfizer and investment firm Bain Capital are partnering to form a company focused on nervous system diseases, including Parkinson’s, Alzheimer’s, epilepsy and addiction, according to CNBC.

Ed Silverman, a senior writer and Pharmalot columnist at STAT, has been covering the pharmaceutical industry for nearly three decades. He is also the author of the morning Pharmalittle newsletter and ...

NEW YORK--(BUSINESS WIRE)-- Pfizer Inc. (NYSE: PFE) today introduced PfizerForAll, a user-friendly digital platform designed to make access to healthcare and managing health and wellness more seamless ...

Program offers significant savings on over 30 brands spanning women’s health, migraine, arthritis, rare disease and moreAffirms Pfizer’s commitment to reduce drug costs for millions of Americans ...

Pfizer Inc. and a pharmacy standards group are teaming up to warn consumers about the risks of counterfeit prescription medicines, which endanger the public and take money from both pharmacies and ...

TRENTON, N.J. (AP) — Pfizer Inc. and a pharmacy standards group are teaming to warn consumers about the risks of counterfeit prescription medicines, which endanger the public and take money from both ...